Abstract
Fourteen years after transplantation into the striatum of an individual with Parkinson's disease, grafted nigral neurons were found to have Lewy body–like inclusions that stained positively for α-synuclein and ubiquitin and to have reduced immunostaining for dopamine transporter. These pathological changes suggest that Parkinson's disease is an ongoing process that can affect grafted cells in the striatum in a manner similar to host dopamine neurons in the substantia nigra. These findings have implications for cell-based therapies and for understanding the cause of Parkinson's disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Distribution of Lewy-related pathology in the brain, spinal cord, and periphery: the population-based Vantaa 85 + study
Acta Neuropathologica Communications Open Access 12 December 2022
-
Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad
Molecular Neurodegeneration Open Access 26 November 2022
-
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
Acta Neuropathologica Communications Open Access 06 September 2022
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.


References
Olanow, C.W. et al. Ann. Neurol. 54, 403–414 (2003).
Freed, C.R. et al. N. Engl. J. Med. 344, 710–719 (2001).
Sawle, G.V. et al. Ann. Neurol. 31, 166–173 (1992).
Piccini, P. et al. Nat. Neurosci. 2, 1137–1140 (1999).
Kordower, J.H. et al. N. Engl. J. Med. 332, 1118–1124 (1995).
Kordower, J.H. et al. J. Comp. Neurol. 370, 203–230 (1996).
Kordower, J.H. et al. Cell Transplant. 6, 213–219 (1997).
Mendez, I. et al. Brain 128, 1498–1510 (2005).
Braak, H. et al. Neurobiol. Aging 24, 197–211 (2003).
Chu, Y. & Kordower, J.H. Neurobiol. Dis. 25, 134–149 (2007).
Olanow, C.W. et al. Lancet Neurol. 3, 496–503 (2004).
Acknowledgements
We would like to thank G. Folino for histological assistance.
Author information
Authors and Affiliations
Contributions
J.H.K. and Y.C. performed the histological analysis. R.A.H. performed the clinical assessments. T.B.F. did brain ascertainment. J.H.K., R.A.H., T.B.F. and C.W.O. wrote the manuscript. C.W.O., T.B.F. and J.H.K. designed the original open label transplant trial. T.B.F. and C.W.O. implemented the original clinical transplant trial.
Corresponding author
Ethics declarations
Competing interests
J.H.K. is a consultant for Ceregene, Inc., Brainstorm, Inc. and Nupathe, Inc. C.W.O. is a consultant for Ceregene, Inc. These companies could benefit from the results of this study.
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1 and 2 (PDF 2618 kb)
Rights and permissions
About this article
Cite this article
Kordower, J., Chu, Y., Hauser, R. et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14, 504–506 (2008). https://doi.org/10.1038/nm1747
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1747
This article is cited by
-
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease
Journal of Neuroinflammation (2022)
-
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
Acta Neuropathologica Communications (2022)
-
Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
Acta Neuropathologica Communications (2022)
-
Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
Journal of Biomedical Science (2022)
-
Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad
Molecular Neurodegeneration (2022)